Variant report
Variant | nsv947297 |
---|---|
Chromosome Location | chr1:102172433-102179644 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:102167808..102170688-chr1:102173598..102175511,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541916273 | chr1:102172482-102172483 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560339136 | chr1:102172489-102172490 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368123772 | chr1:102172492-102172493 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs572286454 | chr1:102172526-102172527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs377717542 | chr1:102172553-102172554 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs374743057 | chr1:102172563-102172564 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs12409136 | chr1:102172575-102172576 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564646468 | chr1:102172593-102172594 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7523828 | chr1:102172619-102172620 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs550314181 | chr1:102172672-102172673 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs57494873 | chr1:102172712-102172713 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs529863514 | chr1:102172783-102172784 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs548285930 | chr1:102172787-102172788 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539116454 | chr1:102172795-102172796 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs72986976 | chr1:102172808-102172809 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs187643692 | chr1:102172893-102172894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570660780 | chr1:102172932-102172933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs138819872 | chr1:102172944-102172945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557426910 | chr1:102172994-102172995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190613031 | chr1:102173008-102173009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574468097 | chr1:102173009-102173010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs12089780 | chr1:102173025-102173026 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs553863714 | chr1:102173026-102173027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183369662 | chr1:102173043-102173044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546083085 | chr1:102173093-102173094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs142006777 | chr1:102173105-102173106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs188651562 | chr1:102173121-102173122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs145717285 | chr1:102173131-102173132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs544094308 | chr1:102173132-102173133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528897816 | chr1:102173135-102173136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565282852 | chr1:102173151-102173152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs35984649 | chr1:102173152-102173153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs376378697 | chr1:102173157-102173158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs529698976 | chr1:102173172-102173173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs575153474 | chr1:102173231-102173232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs541815102 | chr1:102173248-102173249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs74106239 | chr1:102173250-102173251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192764165 | chr1:102173364-102173365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs536833154 | chr1:102173385-102173386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs184473020 | chr1:102173390-102173391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs116369888 | chr1:102173462-102173463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs531534473 | chr1:102173487-102173488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555267921 | chr1:102173489-102173490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573569119 | chr1:102173517-102173518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs115773117 | chr1:102173545-102173546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs535477917 | chr1:102173549-102173550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs535030955 | chr1:102173621-102173622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs187811286 | chr1:102173635-102173636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs137998348 | chr1:102173652-102173653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs116196791 | chr1:102173660-102173661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:102171200-102172800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:102172400-102178000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
3 | chr1:102175000-102175200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr1:102175200-102179000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
5 | chr1:102178000-102178200 | Enhancers | H9 Cell Line | embryonic stem cell |
6 | chr1:102178000-102178200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr1:102178000-102178200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
8 | chr1:102178200-102178800 | Bivalent Enhancer | HUES48 Cell Line | embryonic stem cell |
9 | chr1:102178400-102178800 | Bivalent Enhancer | iPS-20b Cell Line | embryonic stem cell |
10 | chr1:102178400-102180200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr1:102178400-102181000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr1:102178600-102179000 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
13 | chr1:102178600-102181200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr1:102178800-102179000 | Flanking Bivalent TSS/Enh | iPS-20b Cell Line | embryonic stem cell |
15 | chr1:102178800-102179200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr1:102179000-102179400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
17 | chr1:102179000-102179800 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
18 | chr1:102179000-102180600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
19 | chr1:102179200-102179600 | Enhancers | H1 Cell Line | embryonic stem cell |
20 | chr1:102179200-102179800 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
21 | chr1:102179400-102179600 | Flanking Active TSS | iPS-18 Cell Line | embryonic stem cell |
22 | chr1:102179600-102180600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |